Skip to main content
Fig. 2 | Diabetology & Metabolic Syndrome

Fig. 2

From: Effect of dapagliflozin on proteomics and metabolomics of serum from patients with type 2 diabetes

Fig. 2

Functional annotation and enrichment analysis of the differentially abundant proteins in the T2D patients at the baseline and after dapagliflozin treatment. A–C GO functional enrichment analysis of the differentially abundant proteins in the T2D patients after dapagliflozin treatment. The three major categories of enriched GO functional classification: Biological Process (A), Cellular Component (B) and Molecular Function (C). D KEGG functional enrichment analysis of the differentially abundant proteins in the T2D patients after dapagliflozin treatment. The size of the dot represents the number of the differentially abundant proteins annotated to the pathways, and the color of the dot represents the FDR corrected p-value

Back to article page